Loading clinical trials...
Loading clinical trials...
Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact
This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.
PRIMARY OBJECTIVE: I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM). OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial. ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.
Age
35 - 70 years
Sex
MALE
Healthy Volunteers
No
Mayo Clinic in Florida
Jacksonville, Florida, United States
Start Date
August 2, 2021
Primary Completion Date
October 1, 2021
Completion Date
October 1, 2021
Last Updated
November 4, 2024
220
ACTUAL participants
Media Intervention
OTHER
Media Intervention
OTHER
Survey Administration
OTHER
Lead Sponsor
Mayo Clinic
NCT04550494
NCT04857502
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions